UK markets closed

Nano-X Imaging Ltd. (NNOX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.59+0.73 (+9.29%)
At close: 04:00PM EDT
8.59 0.00 (0.00%)
After hours: 07:53PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close7.86
Open8.25
Bid8.57 x 200
Ask8.63 x 300
Day's range8.09 - 8.59
52-week range4.89 - 14.28
Volume921,681
Avg. volume1,000,519
Market cap496.405M
Beta (5Y monthly)2.03
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Innovative Data Featuring Nanox AI Cardiac Solution Showcased at SCCT 2024

    In a study conducted by Brigham & Women’s Hospital, Nanox.AI-Based Analysis helps Reveal Coronary Artery Calcium in over 50% of IMID Patients; Lead author Brittany Weber, MD, PhD, declared as ‘Young Investigator Awards’ Winner In a study conducted by Jefferson Einstein Hospital, Nanox.AI Cardiac Solution Flags CAD High-Risk Patients, Drives Significant Revenue Additional data presented by Corewell Health, Massachusetts General Hospital and Rabin Medical Center PETACH TIKVA, Israel, July 25, 2024

  • GlobeNewswire

    Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of Cardiovascular Computed Tomography

    PETACH TIKVA, Israel, June 25, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that data from five studies supporting the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox AI, will be presented at the 19th Annual Meeting of the Society of Cardiovascular Computed Tomography (SCCT), being held July 18-21 in Washington, D.C. The studies are being presented by esteemed institutions Brigha

  • GlobeNewswire

    Nanox Launches Artificial Intelligence Functionality in Second Opinions Platform

    Nanox integrates FDA-cleared population health AI solutions into its Second Opinions service New AI capabilities available to patients who submit chest and abdominal CT scans for second opinions Offering the power of Artificial Intelligence to their second opinion CT report to promote early detection of chronic conditions PETACH TIKVA, Israel, June 05, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today ann